A step towards a Health Union or a blow to the EU’s competitiveness: stakeholder reactions to the Pharmaceutical Package
On 26 April, after months of delay, the European Commission published its long-awaited proposed reform of the pharmaceutical legislation. The largest overhaul of the EU’s health legislation in over 20 years, the “Pharma Package” focuses on supporting both drug availability and affordability and investment in health innovation by making pharmaceutical incentives more conditional. Heated debates […]
Read more
